© The Financial Times Ltd 2014 FT and 'Financial Times' are trademarks of The Financial Times Ltd.
As of Jul 18, 2014, the consensus forecast amongst 2 polled investment analysts covering GW Pharmaceuticals plc advises investors to purchase equity in the company. This has been the consensus forecast since the sentiment of investment analysts improved on Jun 06, 2013. The previous consensus forecast advised that GW Pharmaceuticals plc would outperform the market.
|Last year||3 months ago||2 months ago||4 weeks ago||Latest|
The 2 analysts offering 12 month price targets for
Dividend information is not available for
On May 07, 2014,
The next earnings announcement is expected on Aug 04, 2014. View Full Interim Financials
|Average growth rate||--|
|Average growth rate||+44.05 %|
GW Pharmaceuticals plc had 2nd quarter 2014 revenues of 7.5270m. This missed the 335.5535m consensus estimate of the 4 analysts following the company. This was 0.53% above the prior year's 2nd quarter results. View Full Interim Financials
|Average growth rate||+0.53 %|
GW Pharmaceuticals plc had revenues for the full year 2013 of 27.2950m. This was 17.59 % below the prior year's results. View Full Annual Financials
|Average growth rate||+4.49 %|